544 related articles for article (PubMed ID: 20965300)
1. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
2. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder.
Wiffen BD; Rabinowitz J; Fleischhacker WW; David AS
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):169-75. PubMed ID: 20880827
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
4. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
5. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
Novak L; Svab V
Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
[TBL] [Abstract][Full Text] [Related]
7. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.
Jónsdóttir H; Friis S; Horne R; Pettersen KI; Reikvam A; Andreassen OA
Acta Psychiatr Scand; 2009 Jan; 119(1):78-84. PubMed ID: 18983630
[TBL] [Abstract][Full Text] [Related]
8. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
9. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Stanković Z; Britvić D; Vuković O; Ille T
Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
11. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
12. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
14. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
15. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
Tsang HW; Fung KM; Corrigan PW
J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
[TBL] [Abstract][Full Text] [Related]
18. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.
Klingberg S; Schneider S; Wittorf A; Buchkremer G; Wiedemann G
Psychiatry Res; 2008 Nov; 161(2):225-34. PubMed ID: 18922582
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
20. Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics.
Kao YC; Liu YP; Chou MK; Cheng TH
Compr Psychiatry; 2011; 52(2):171-80. PubMed ID: 21295224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]